Interleukin-2
Showing 1 - 25 of >10,000
Alzheimer Trial in Houston (Interleukin-2, Placebo)
Recruiting
- Alzheimer Disease
- Interleukin-2
- Placebo
-
Houston, TexasHouston Methodist Research Institute
Oct 17, 2023
Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))
Not yet recruiting
- Pancreatic Cancer
- +3 more
- Histamine Dihydrochloride (HDC)
- Interleukin-2 (IL-2)
- (no location specified)
Mar 31, 2023
TIA, Carotid Artery Plaque, Carotid Atherosclerosis Trial in Cambridge (Interleukin-2 [IL-2], Standard care - Carotid
Not yet recruiting
- TIA
- +2 more
- Interleukin-2 [IL-2]
- Standard care - Carotid Endarterectomy
-
Cambridge, Cambridgeshire, United KingdomAddenbrookes Hospital
Aug 2, 2023
Dermatomyositis Trial (Interleukin-2)
Not yet recruiting
- Dermatomyositis
- Interleukin-2
- (no location specified)
Aug 8, 2022
Sjögren's Syndrome Trial in Beijing (low-dose interleukin-2, rapamycin)
Recruiting
- Sjögren's Syndrome
- low-dose interleukin-2
- rapamycin
-
Beijing, Beijing, ChinaPeking university people's hospital
Dec 2, 2022
HIV Infection Trial in Cleveland (Recombinant Interleukin-2)
Terminated
- HIV Infection
- Recombinant Interleukin-2
-
Cleveland, OhioAIDS Clinical Trials Unit
Sep 1, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in
Not yet recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Biospecimen Collection
- +8 more
-
Kansas City, KansasUniversity of Kansas Cancer Center
Nov 27, 2023
Systemic Lupus Erythematosus Trial in Changchun (IL-2)
Completed
- Systemic Lupus Erythematosus
-
Changchun, Changchun/Jilin, ChinaSirui Yang
Aug 16, 2022
Solid Tumor Trial in Seoul (TASO-001((TGF-ß2 targeting anti-sense oligonucleotide), Aldesleukin)
Recruiting
- Solid Tumor
- TASO-001((TGF-β2 targeting anti-sense oligonucleotide)
- Aldesleukin
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 31, 2023
Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)
Active, not recruiting
- Kidney Cancer
- Pembrolizumab
- Interleukin-2
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jun 21, 2022
Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))
Completed
- Pleural Mesothelioma
- Cyclophosphamide
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)
Not yet recruiting
- Triple Negative Breast Cancer
- Proleukin 1.3 MG Injection
- (no location specified)
Apr 6, 2023
Acute Coronary Syndromes Trial in Cambridge (Interleukin-2 [IL-2], Placebo Dextrose 5% solution)
Recruiting
- Acute Coronary Syndromes
- Interleukin-2 [IL-2]
- Placebo Dextrose 5% solution
-
Cambridge, Cambridgeshire, United KingdomAddenbrooke's Hospital
May 31, 2022
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Atlanta (Aldesleukin,
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Aldesleukin
- Pembrolizumab
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Aug 8, 2022
Chronic GVHD Trial in Duarte (biological, procedure, other)
Active, not recruiting
- Chronic Graft Versus Host Disease
- Aldesleukin
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Melanoma (Skin), Melanoma in Situ Trial in Halifax (Aldesleukin, Saline)
Suspended
- Melanoma (Skin)
- Melanoma in Situ
- Aldesleukin
- Saline
-
Halifax, Nova Scotia, CanadaQueen Elizabeth II Health Sciences Centre
Jul 18, 2022
HIV-1 Infections Trial in Washington (HAART, T cells)
Completed
- HIV-1 Infections
- HAART
- T cells
-
Washington, District of ColumbiaWalter Reed Army Medical Center
Aug 17, 2022
Advanced Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Seattle (Aldesleukin,
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +3 more
- Aldesleukin
- Pembrolizumab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 5, 2022
Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)
Active, not recruiting
- Malignant Neoplasm
- aldesleukin
- +7 more
-
Los Angeles, CaliforniaUniversity of California at Los Angeles (UCLA )
Dec 1, 2022
Renal Cell Carcinoma Trial in Portland (High Dose IL-2, SBRT)
Active, not recruiting
- Renal Cell Carcinoma
- High Dose IL-2
- SBRT
-
Portland, OregonPortland Providence Medical Center
Jan 31, 2022
Autoimmune Diseases, Inflammatory Disease, Acquired Bone Marrow Aplasia Trial (Blood sample taken at a single time point)
Not yet recruiting
- Autoimmune Diseases
- +10 more
- Blood sample taken at a single time point
- (no location specified)
Sep 14, 2022
Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)
Recruiting
- Neuroblastoma Recurrent
- Natural killer cell
- +4 more
-
Hong Kong, Hong KongHong Kong Children's Hospital
Feb 22, 2023
Renal Cell Carcinoma Trial in United States (Entinostat, Interleukin-2)
Active, not recruiting
- Renal Cell Carcinoma
- Entinostat
- Interleukin-2
-
Los Angeles, California
- +4 more
Feb 14, 2022